Adjusted EPS came in at $0.76, just under the analyst estimate of $0.78. Total revenue for the quarter ... offering a robust ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a technology collaboration and licence agreement with Berlin-based Eckert & Ziegler SE (EZAG) for ...